Advertisement
Screener

UNICYCIVE THERAPEUTICS, INC. (UNCY) Form D

UNICYCIVE THERAPEUTICS, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2020-06-03: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-10-01; Total offering amount $604,140.
  • 2019-08-16: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-03-12; Total offering amount $526,950.
  • 2019-03-04: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-02-21; Total offering amount $420,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2020-06-03Rule 506(b)Equity2019-10-01$604,140$604,140$015
2019-08-16Rule 506(b)Equity2019-03-12$526,950$526,950$09
2019-03-04Rule 506(b)Equity2019-02-21$420,000$420,000$08

Similar stocks

Stock NameCountryMarket CapPE Ratio
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
MEDICINOVA INC (MNOV)United States$0.130B-6.04
Atrium Therapeutics, Inc. (RNA)United States$0.140B
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72